Related Experiment Video

Updated: May 22, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Chemoprevention of breast cancer by dietary compounds

Aditi S Vadodkar1, Suman Suman, Rajkumar Lakshmanaswamy

  • 1Center of Excellence in Cancer Research, Department of Biomedical Sciences, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA.

Anti-Cancer Agents in Medicinal Chemistry
|May 16, 2012
PubMed

Insights

Natural compounds offer promising, less toxic alternatives for breast cancer prevention and treatment. Phytochemicals can inhibit cancer growth by targeting key cellular pathways and inducing apoptosis.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Preventive Medicine

Background:

  • Breast cancer is a leading cause of cancer-related deaths globally, necessitating novel therapeutic and preventive strategies.
  • Natural products, including phytochemicals, have a long history of use in treating illnesses due to their safety and availability.
  • Many phytochemicals are under investigation for their potential anticancer properties.

Purpose of the Study:

  • To review potential natural compounds for cancer prevention, focusing on breast cancer.
  • To discuss the mechanisms by which phytochemicals interact with cellular signaling pathways.
  • To explore the role of these compounds in suppressing breast cancer cell growth.

Main Methods:

  • Literature review of preclinical and clinical studies on natural products and phytochemicals.
  • Analysis of mechanistic data on phytochemical interactions with cellular signal transduction pathways.
  • Examination of evidence for phytochemicals' effects on carcinogenesis and cancer cell suppression.

Main Results:

  • Phytochemicals demonstrate potential in reducing cancer risk and inhibiting tumor development.
  • Mechanisms include induction of antioxidant and detoxifying enzymes, regulation of inflammatory pathways, and promotion of apoptosis.
  • Natural compounds show promise in suppressing breast cancer cell proliferation.

Conclusions:

  • Dietary phytochemicals represent a viable strategy for breast cancer prevention and therapy.
  • Understanding their molecular interactions is key to developing effective natural product-based treatments.
  • Further research into these compounds could lead to safer, less toxic cancer interventions.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...